The Guardian
Email YouTube Facebook Instagram Twitter WhatsApp

NAPHARM warns against putting medicine on concurrent list

Related

Director General, NAFDAC, Prof. Mojisola Christianah Adeyeye


Says Move Will Worsen Drugs Misuse

The Nigerian Academy of Pharmacy (NAPHARM) has condemned a recent proposition published in a daily newspaper to move drug matters, presently on the exclusive list, to the concurrent.The body warned that it would be counter-productive and damaging to the country.
 
This was disclosed at a reception in honour of two distinguished fellows of the Academy, Prof. Mojisola Adeyeye, Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), and Prof. Chinedum Peace Babalola, Vice Chancellor, Chrisland University.

President, Nigeria Academy of Pharmacy, Prince Julius, noted that the Academy wished to strongly advise that the health needs of Nigerians are best served by retaining medicines on the exclusive list.

“This is particularly critical, if we are to avert a worsening of the chaos of drug distribution across the country and the nightmare this poses for regulatory control,” he said.

He warned that the country has clearly transited from being a mere courier to one where young people now actively abuse drugs and hard substances. He said this is another strong imperative for aggressive regulatory control backed by legislation, to control the availability of drugs and other controlled substances across the country.


Receive News Alerts on Whatsapp: +2348136370421

No comments yet